Chemotherapy impedes in vitro microcirculation and promotes migration of leukemic cells with impact on metastasis

Sruti V. Prathivadhi-Bhayankaram, Jianhao Ning, Michael Mimlitz, Carolyn Taylor, Erin M. Gross, Michael G. Nichols, Jochen Guck, Andrew Ekpenyong

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Although most cancer drugs target the proliferation of cancer cells, it is metastasis, the complex process by which cancer cells spread from the primary tumor to other tissues and organs of the body where they form new tumors, that leads to over 90% of all cancer deaths. Thus, there is an urgent need for anti-metastasis therapy. Surprisingly, emerging evidence suggests that certain anti-cancer drugs such as paclitaxel and doxorubicin can actually promote metastasis, but the mechanism(s) behind their pro-metastatic effects are still unclear. Here, we use a microfluidic microcirculation mimetic (MMM) platform which mimics the capillary constrictions of the pulmonary and peripheral microcirculation, to determine if in-vivo-like mechanical stimuli can evoke different responses from cells subjected to various cancer drugs. In particular, we show that leukemic cancer cells treated with doxorubicin and daunorubicin, commonly used anti-cancer drugs, have over 100% longer transit times through the device, compared to untreated leukemic cells. Such delays in the microcirculation are known to promote extravasation of cells, a key step in the metastatic cascade. Furthermore, we report a significant (p < 0.01) increase in the chemotactic migration of the doxorubicin treated leukemic cells. Both enhanced retention in the microcirculation and enhanced migration following chemotherapy, are pro-metastatic effects which can serve as new targets for anti-metastatic drugs.

Original languageEnglish (US)
Pages (from-to)841-846
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume479
Issue number4
DOIs
StatePublished - Oct 28 2016

Fingerprint

Microcirculation
Chemotherapy
Cell Movement
Cells
Neoplasm Metastasis
Drug Therapy
Doxorubicin
Pharmaceutical Preparations
Neoplasms
Tumors
Daunorubicin
Paclitaxel
Microfluidics
In Vitro Techniques
Tissue
Constriction
Cell Proliferation

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Chemotherapy impedes in vitro microcirculation and promotes migration of leukemic cells with impact on metastasis. / Prathivadhi-Bhayankaram, Sruti V.; Ning, Jianhao; Mimlitz, Michael; Taylor, Carolyn; Gross, Erin M.; Nichols, Michael G.; Guck, Jochen; Ekpenyong, Andrew.

In: Biochemical and Biophysical Research Communications, Vol. 479, No. 4, 28.10.2016, p. 841-846.

Research output: Contribution to journalArticle

Prathivadhi-Bhayankaram, Sruti V. ; Ning, Jianhao ; Mimlitz, Michael ; Taylor, Carolyn ; Gross, Erin M. ; Nichols, Michael G. ; Guck, Jochen ; Ekpenyong, Andrew. / Chemotherapy impedes in vitro microcirculation and promotes migration of leukemic cells with impact on metastasis. In: Biochemical and Biophysical Research Communications. 2016 ; Vol. 479, No. 4. pp. 841-846.
@article{e56177fa877c488f8e9021f25f8fa7e1,
title = "Chemotherapy impedes in vitro microcirculation and promotes migration of leukemic cells with impact on metastasis",
abstract = "Although most cancer drugs target the proliferation of cancer cells, it is metastasis, the complex process by which cancer cells spread from the primary tumor to other tissues and organs of the body where they form new tumors, that leads to over 90{\%} of all cancer deaths. Thus, there is an urgent need for anti-metastasis therapy. Surprisingly, emerging evidence suggests that certain anti-cancer drugs such as paclitaxel and doxorubicin can actually promote metastasis, but the mechanism(s) behind their pro-metastatic effects are still unclear. Here, we use a microfluidic microcirculation mimetic (MMM) platform which mimics the capillary constrictions of the pulmonary and peripheral microcirculation, to determine if in-vivo-like mechanical stimuli can evoke different responses from cells subjected to various cancer drugs. In particular, we show that leukemic cancer cells treated with doxorubicin and daunorubicin, commonly used anti-cancer drugs, have over 100{\%} longer transit times through the device, compared to untreated leukemic cells. Such delays in the microcirculation are known to promote extravasation of cells, a key step in the metastatic cascade. Furthermore, we report a significant (p < 0.01) increase in the chemotactic migration of the doxorubicin treated leukemic cells. Both enhanced retention in the microcirculation and enhanced migration following chemotherapy, are pro-metastatic effects which can serve as new targets for anti-metastatic drugs.",
author = "Prathivadhi-Bhayankaram, {Sruti V.} and Jianhao Ning and Michael Mimlitz and Carolyn Taylor and Gross, {Erin M.} and Nichols, {Michael G.} and Jochen Guck and Andrew Ekpenyong",
year = "2016",
month = "10",
day = "28",
doi = "10.1016/j.bbrc.2016.09.121",
language = "English (US)",
volume = "479",
pages = "841--846",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Chemotherapy impedes in vitro microcirculation and promotes migration of leukemic cells with impact on metastasis

AU - Prathivadhi-Bhayankaram, Sruti V.

AU - Ning, Jianhao

AU - Mimlitz, Michael

AU - Taylor, Carolyn

AU - Gross, Erin M.

AU - Nichols, Michael G.

AU - Guck, Jochen

AU - Ekpenyong, Andrew

PY - 2016/10/28

Y1 - 2016/10/28

N2 - Although most cancer drugs target the proliferation of cancer cells, it is metastasis, the complex process by which cancer cells spread from the primary tumor to other tissues and organs of the body where they form new tumors, that leads to over 90% of all cancer deaths. Thus, there is an urgent need for anti-metastasis therapy. Surprisingly, emerging evidence suggests that certain anti-cancer drugs such as paclitaxel and doxorubicin can actually promote metastasis, but the mechanism(s) behind their pro-metastatic effects are still unclear. Here, we use a microfluidic microcirculation mimetic (MMM) platform which mimics the capillary constrictions of the pulmonary and peripheral microcirculation, to determine if in-vivo-like mechanical stimuli can evoke different responses from cells subjected to various cancer drugs. In particular, we show that leukemic cancer cells treated with doxorubicin and daunorubicin, commonly used anti-cancer drugs, have over 100% longer transit times through the device, compared to untreated leukemic cells. Such delays in the microcirculation are known to promote extravasation of cells, a key step in the metastatic cascade. Furthermore, we report a significant (p < 0.01) increase in the chemotactic migration of the doxorubicin treated leukemic cells. Both enhanced retention in the microcirculation and enhanced migration following chemotherapy, are pro-metastatic effects which can serve as new targets for anti-metastatic drugs.

AB - Although most cancer drugs target the proliferation of cancer cells, it is metastasis, the complex process by which cancer cells spread from the primary tumor to other tissues and organs of the body where they form new tumors, that leads to over 90% of all cancer deaths. Thus, there is an urgent need for anti-metastasis therapy. Surprisingly, emerging evidence suggests that certain anti-cancer drugs such as paclitaxel and doxorubicin can actually promote metastasis, but the mechanism(s) behind their pro-metastatic effects are still unclear. Here, we use a microfluidic microcirculation mimetic (MMM) platform which mimics the capillary constrictions of the pulmonary and peripheral microcirculation, to determine if in-vivo-like mechanical stimuli can evoke different responses from cells subjected to various cancer drugs. In particular, we show that leukemic cancer cells treated with doxorubicin and daunorubicin, commonly used anti-cancer drugs, have over 100% longer transit times through the device, compared to untreated leukemic cells. Such delays in the microcirculation are known to promote extravasation of cells, a key step in the metastatic cascade. Furthermore, we report a significant (p < 0.01) increase in the chemotactic migration of the doxorubicin treated leukemic cells. Both enhanced retention in the microcirculation and enhanced migration following chemotherapy, are pro-metastatic effects which can serve as new targets for anti-metastatic drugs.

UR - http://www.scopus.com/inward/record.url?scp=84991578305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991578305&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2016.09.121

DO - 10.1016/j.bbrc.2016.09.121

M3 - Article

VL - 479

SP - 841

EP - 846

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 4

ER -